Literature DB >> 30982997

Chronicity of mental comorbidity in children with new-onset physical illness.

Shannon V Reaume1, Mark A Ferro1.   

Abstract

BACKGROUND: Evidence suggests that physical and mental illnesses are strongly correlated in children. This study examined patterns of the chronicity of multimorbidity (co-occurring physical and mental illness); estimated homotypic continuity; and modelled factors associated with chronicity in children newly diagnosed with a chronic physical illness.
METHODS: Children aged 6-16 years diagnosed with one of asthma, diabetes, epilepsy, food allergy, or juvenile arthritis were recruited from two children's hospitals and followed for 6 months. Child mental illness was measured using the parent-reported Mini International Neuropsychiatric Interview and Ontario Child Health Study Emotional Behavioural Scales at baseline and 6 months later. Children were stratified into three groups: no multimorbidity, acute (multimorbidity at only one assessment), and persistent (multimorbidity at both assessments).
RESULTS: Forty-nine children were available for analysis: no multimorbidity (n = 18), acute (n = 13), and persistent (n = 18). Homotypic continuity was highest for conduct disorder (67.5%) and lowest for major depression (16.7%). Unadjusted analyses showed positive associations between child and parent behavioural symptoms, as well as family functioning with persistent multimorbidity. These associations remained after adjustment, ranging from odds ratio (OR) = 1.29 [1.01, 1.64] for depression to OR = 1.61 [1.11, 2.33] and OR = 1.61 [1.10, 2.35] for attention-deficit hyperactivity and oppositional defiant, respectively, in child models. In parent models, associations remained for parental anxiety (OR = 1.18 [1.04, 1.34]) and stress (OR = 1.15 [1.02, 1.31]).
CONCLUSIONS: Multimorbidity is persistent in children newly diagnosed with physical illnesses, regardless of the mental comorbidity experienced. Integrating family-centred mental health services soon after the diagnosis of a physical illness should be prioritized in pediatric settings.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  adolescent; chronic disease; mental disorder; multimorbidity; prospective cohort

Mesh:

Year:  2019        PMID: 30982997     DOI: 10.1111/cch.12667

Source DB:  PubMed          Journal:  Child Care Health Dev        ISSN: 0305-1862            Impact factor:   2.508


  6 in total

1.  Cohort Profile: Multimorbidity in Children and Youth Across the Life-course (MY LIFE) Study.

Authors:  Mark A Ferro; Ellen L Lipman; Ryan J Van Lieshout; Brian Timmons; Lilly Shanahan; Jan Willem Gorter; Kathy Georgiades; Michael Boyle
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2021-05-01

Review 2.  Physical-mental multimorbidity in children and youth: a scoping review.

Authors:  Isabella Romano; Claire Buchan; Leonardo Baiocco-Romano; Mark A Ferro
Journal:  BMJ Open       Date:  2021-05-20       Impact factor: 2.692

3.  Multimorbidity in Children and Youth Across the Life-course (MY LIFE): protocol of a Canadian prospective study.

Authors:  Mark A Ferro; Ellen L Lipman; Ryan J Van Lieshout; Jan Willem Gorter; Lilly Shanahan; Michael Boyle; Kathy Georgiades; Brian Timmons
Journal:  BMJ Open       Date:  2019-11-03       Impact factor: 2.692

Review 4.  Young Minds: Mental Health and Transitional Care in Adolescent and Young Adult Rheumatology.

Authors:  Jason Palman; Janet E McDonagh
Journal:  Open Access Rheumatol       Date:  2020-12-07

5.  The centrality of disclosure decisions to the illness experience for youth with chronic conditions: A qualitative study.

Authors:  Roberta Lynn Woodgate; Pauline Tennent; Sarah Barriage; Nicole Legras
Journal:  J Health Psychol       Date:  2020-09-28

6.  Prevalence and Correlates of Physical-mental Multimorbidity in Outpatient Children From a Pediatric Hospital in Canada.

Authors:  Mark A Ferro; Saad Qureshi; Ryan J Van Lieshout; Ellen L Lipman; Kathy Georgiades; Jan Willem Gorter; Brian W Timmons; Lilly Shanahan
Journal:  Can J Psychiatry       Date:  2022-01-21       Impact factor: 5.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.